Study of Vitamin B 12 deficiency and peripheral neuropathy in metformin-treated early Type 2 diabetes mellitus

Indian Journal of Endocrinology and Metabolism

Volumn 20, Issue 5, 2016, Pages 631-637

  Roy, Rudra Prasad ^a   Ghosh, Kaushik ^b   Ghosh, Manas ^b   Acharyya, Amitava ^c   Bhattacharya, Ambarish ^d   Pal, Mrinal ^e   Chakraborty, Sisir ^f   Sengupta, Nilanjan ^g  

^a Vivekananda Hospital Pvt Ltd   (India)

^b Murshidabad Medical College   (India)

^c Independent Public Health Consultant   (India)

^d Charnock Hospital   (India)

^e BURDWAN MEDICAL COLLEGE AND HOSPITAL   (India)

^f India   (India)

^g NRS MEDICAL COLLEGE   (India)

Author keywords

Diabetes mellitus; metformin; screening; Vitamin B 12 deficiency

Indexed keywords

EID: 84988591454     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.190542     Document Type: Article

References (26)

1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 321: 405-12
2. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703-13
3. Haffner SM. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: Implications for the prevention of coronary heart disease. Diabetes Care 1997; 20: 469-71
4. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D?Agostino RB, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study. Ann Intern Med 1999; 131: 352-5
5. Brattström LE, Israelsson B, Jeppsson JO, Hultberg BL. Folic acid-An innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988; 48: 215-21
6. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study. Arterioscler Thromb Vasc Biol 1998; 18: 133-8
7. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995; 333: 541-9
8. Caspary WF, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and Vitamin-B12-absorption in diabetics on biguanides. Diabetologia 1977; 13: 187-93
9. Carlsen SM, Følling I, Grill V, Bjerve KS, Schneede J, Refsum H. Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease. Scand J Clin Lab Invest 1997; 57: 521-7
10. Aarsand AK, Carlsen SM. Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment. J Intern Med 1998; 244: 169-74
11. Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van Der Burg B, et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and Vitamin B12 in type 2 diabetes mellitus: A randomized, placebo-controlled trial. J Intern Med 2003; 254: 455-63
12. Tomkin GH, Hadden DR, Weaver JA, Montgomery DA. Vitamin-B12 status of patients on long-term metformin therapy. Br Med J 1971; 2: 685-7
13. Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: Is routine screening and supplementation justified? J Diabetes Metab Disord 2013; 12: 17
14. Davis SN. Insulin, oral hypoglycaemic agents and the pharmacology of the endocrine pancreas. The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 1613-45
15. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaquist D, Topolski R. The prevalence of Vitamin B (12) deficiency in patients with type 2 diabetes: A cross-sectional study. J Am Board Fam Med 2009; 22: 528-34
16. Wile DJ, Toth C. Association of metformin, elevated homocysteine and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care 2010; 33: 156-61
17. Liu KW, Dai LK, Woo J. Metformin related Vitamin B12 deficiency. Oxf J Med Age Ageing 2006; 35: 200-2
18. Adams JF, Clark JS, Ireland JT, Kesson CM, Watson WS. Malabsorption of Vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia 1983; 24: 16-8
19. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B12 deficiency with metformin therapy and Vitamin B12 supplements: The National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2012; 35: 327-33
20. Chen S, Lansdown JA, Moat SJ, Ellis R, Goringe A, Dunstan DF, et al. An observational study of the effect of metformin on B12 status and peripheral neuropathy. Br J Diabetes Vascular Dis 2012; 12: 189-93
21. Bell DS. Metformin-induced Vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010; 103: 265-7
22. Pierce SA, Chung AH, Black KK. Evaluation of Vitamin B12 monitoring in a veteran population on long-term, high-dose metformin therapy. Ann Pharmacother 2012; 46: 1470-6
23. Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, et al. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes. Eur J Endocrinol 2008; 158: 35-46
24. Gale EA, Anderson JV. Diabetes mellitus and other disorders of metabolism. Kumar and Clark?s Clinical Medicine 7th ed., Ch. 19. Oxford: Elsevier; 2010. p. 1029-63
25. Powers AC. Diabetes mellitus. Harrison?s Principles of Internal Medicine. Part 16. 18th ed., Ch. 344. London: The McGraw-Hill Companies; 2012. p. 2968-3003
26. Kumthekar AA, Gidwani HV, Kumthekar AB. Metformin associated B12 deficiency. J Assoc Physicians India 2012; 60: 58-60